Oliver Reuss is the Executive Director and Investment Manager at Boehringer Ingelheim Venture Fund, where they leverage their background in molecular biology to influence investment strategies. They serve on the boards of several companies, including Dopavision, Brainomix, Aignostics, C-mo, and Glox, focusing on innovations in healthcare and digital therapeutics. Oliver's previous roles include a postdoctoral position at the University of Würzburg and various management positions at Boehringer Ingelheim. They have also contributed to investment committees at HTGF and continue to advance healthcare solutions through their board memberships. Oliver holds a PhD and a Diploma in Biology from Bayerische Julius-Maximillians University of Würzburg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices